Dexpramipexole Placebo

DRUG2 trials

Sponsors

Knopp Biosciences

Conditions

Amyotrophic Lateral Sclerosis

Phase 1

Dexpramipexole SAD/MAD Study

CompletedNCT01449578

Knopp BiosciencesAmyotrophic Lateral Sclerosis

Start: 2011-11-30End: 2012-01-31Updated: 2014-11-25

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

CompletedNCT01511029

Knopp BiosciencesAmyotrophic Lateral Sclerosis

Start: 2012-01-31End: 2012-05-31Updated: 2014-11-25